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lifestyle habits and risk of stroke
Consider sex and stroke 
subtypes 
The finding reported by Myint et al that lifestyle 
habits have beneficial effects on stroke 
occurrence is very reassuring and support 
previous results of large scale, US based cohort 
studies.1‑3 Several points merit further comment. 
Firstly, while the authors show several 
multivariable models, their main relative 
risk estimates come from a model that also 
controlled for body mass index, systolic blood 
pressure, and cholesterol concentration. These 
factors are, however, strongly influenced by 
lifestyle habits and can be considered potential 
mediators of the association between lifestyle 
habits and stroke. In addition, controlling for 
potential direct consequences of exposure may 
lead to biased effect estimates.4 Lifestyle habits 
may thus have an even stronger influence on 
stroke occurrence. 
Secondly, the association between lifestyle 
habits and risk of stroke in the study is magnified 
in women. Compared with men who have a 
combination of all four lifestyle habits, women 
seem to achieve a similar risk reduction with 
merely two such habits. Lastly, the EPIC‑Norfolk 
data do not allow differentiation between 
ischaemic and haemorrhagic stroke. Data from 
the Women’s Health Study show that a lifestyle 
considered to be healthy was associated with 
markedly reduced risk of ischaemic, but not 
haemorrhagic, stroke.2 The risk of haemorrhagic 
stroke was highest for women who were 
classified to live the “healthiest” lifestyle.
The data from the study by Myint et al strongly 
support the influence of lifestyle habits on 
stroke risk, and all efforts should be made to 
emphasise a healthy lifestyle. Future research 
should focus on potential differences between 
the sexes of the association between overall 
and specific lifestyle habits and stroke as well 
as on potential differences of lifestyle habits on 
major stroke subtypes.
Tobias Kurth senior researcher, INSerM Unit 
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authors’ reply
We agree with Kurth that intermediate risk factors 
for stroke such as body mass index, systolic 
blood pressure, and cholesterol concentration 
are influenced by the lifestyle factors that we 
examined. This could lead to the attenuation 
of our results, as highlighted by Kurth. The 
observed relations seemed to be over and above 
the impact on these potential mediators on 
stroke risk.
We also agree that the underlying 
pathophysiology differs between ischaemic and 
haemorrhagic stroke and that it is possible that 
men and women may differ. Nevertheless, the 
assertion by Kurth, based on findings from the 
Women’s Health Study, that haemorrhagic stroke 
was highest for women with healthiest lifestyle1 
requires further exploration given the small 
number of outcomes in their study with reported 
adjusted hazard ratio of 1.27 (95% confidence 
interval 0.37 to 4.29; P=0.62 for trend) with 
non‑significant results for haemorrhagic stroke. 
Although it is possible that differences exist 
between health behaviours and stroke subtypes 
in men and women, the current study did not 
have adequate power to examine this. However, 
it is reassuring that the relations were observed 
with total stroke events, irrespective of subtypes.
Until further evidence provides support for 
Kurth’s assertion, the overwhelming evidence 
supports the role of positive health behaviours to 
prevent stroke. We agree with Kurth that having 
deeper insight into and a better understanding 
of differences between the sexes and potential 
effect of lifestyle behaviours on different stroke 
subtype would be the way forward.
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allergies hysteria is just nuts
Some auto-injection pens  
are counterintuitive
Type I allergy carries the risk of incorrect self 
treatment.1 In patients with type I allergy and 
established systemic reactions, treatment 
includes self injection of adrenaline with 
prefilled devices—the EpiPen device is 
constructed to look like a ballpoint pen. 
Unfortunately it is constructed as an upside‑
down pen: the needle emerges from what at 
first glance seems to be the button end of the 
pen, not the end where one would expect the 
ink covered ballpoint tip to emerge.
Consequently, during the 2008 wasp season, 
we experienced two cases of adverse self 
injection in the thumb. Sixty seven patients 
with wasp stings were seen, 16 of whom 
presented with systemic allergic reactions. 
Six of the 16 were already known to have such 
reactions and had attempted auto‑injection 
of adrenaline. In two of the six patients, the 
procedure was wrongly performed: one auto‑
injected into the thumb, and another never 
received adrenaline because his daughter, 
a consultant in anaesthesia, auto‑injected 
into her thumb when trying to help him. 
Most adrenaline self treatments are correctly 
performed, but our unfortunate patients are not 
alone,2‑4 and in a study using EpiPen dummies, 
16 of 100 doctors injected into their thumb 
when trying to demonstrate a correct auto‑
injection.5
Incorrect self injection is life threatening 
and not easily avoidable through education 
if doctors, even including a consultant in 
anesthaesia, cannot perform the procedure 
correctly. Adrenaline auto‑injection treatment 
must be based on a 100% self evident injection 
procedure.
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Mrsa screening 
Clarity is needed on which  
sites to screen
Kluytmans and Struelens, in their clinical review 
on meticillin resistant Staphylococcus aureus 
(MRSA) in hospital, concluded that the most 
important site to screen for MRSA carriage was 
the nose and that screening other non‑clinical 
sites (perineum, groin, or axilla) was not useful.1
This is contrary to the practice in most UK 
hospitals, where the perineum and groin are 
also screened on the basis of the national 
guidelines published in 2006.2 Screening the 
nose alone will detect around 80% of carriers; 
including the perineum increases this to 93%.3 
Not only is the overall detection rate increased, 
but detection of perineal carriers is important 
because this is correlated with more heavy 
dispersal of MRSA into the environment.4 5
This is an important issue for trusts having 
to implement the Department of Health’s 
requirement to screen all elective admissions 
by 1 April 2009. The two sets of operational 
guidance do not specify which sites should be 
screened apart from the nose, and it is left to 
the microbiologist and infection prevention and 
control teams to make the decision.
The guidance should be clearer and either 
accept that some heavy shedders of MRSA will 
be missed by screening the nose only, or include 
a perineal screen which will require both extra 
resources in nursing time to obtain the screen 
and laboratory cost and time to process the 
additional samples.
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diagnosis of heart failure
ontological fallacy in  
heart failure
Echocardiography1 has resulted in the belief 
that heart failure and reduced ejection fraction 
are synonymous. Recently, however, the 
utility of ejection fraction in diagnosis has 
been undermined by epidemiological studies, 
which have shown that ejection fraction is 
continuously distributed in populations with 
heart failure,2 and that survival is the same 
irrespective of whether there is heart failure 
with normal ejection fraction (HFNEF) or with 
reduced ejection fraction (HFREF).3 4 In effect 
it is the clinical label of heart failure that 
drives prognosis, not the ejection fraction. The 
adoption of a dichotomous value (the division 
of cardiac function into normal and reduced 
ejection fraction) to describe a continuous 
variable is now outmoded and unhelpful. 
The relative lack of benefit in studies in 
HFNEF may be a failure of the therapeutic 
modes of action of the drugs studied, since 
there is no physiological reason why afterload 
reduction in non‑dilated hearts will produce 
prognostic benefit. We may be trying the wrong 
drugs because we do not fully understand the 
condition. We do not understand the condition 
because our terms of reference are those of 
echocardiography.
HFREF is characterised by ventricular dilation 
and HFNEF by normal left ventricular end diastolic 
diameter. Both, however, display markedly 
raised left atrial pressure, although this is often 
difficult to measure with echocardiography. 
Brain natriuretic peptide, a marker of cardiac wall 
stress, is elevated in both conditions. HFREF and 
HFNEF also share many clinical features (usually 
characterised by congestion) and an equally poor 
prognosis.
Gale refers to the ontological fallacy into 
which we fall when we invent categories for our 
own convenience and then treat them as if they 
had a real existence.5 By bestowing diagnostic 
supremacy on an ontological fallacy in heart 
failure we have allowed the ejection fraction 
to usurp our thinking and warp our semantics 
(HFNEF, HFREF, etc). We need to reopen our 
minds to completely understand this fatal 
congestive syndrome.
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don’t turn old people into patients
Wanted: age adjusted outcomes
Who really knows what elderly individuals 
want and need in terms of health care?1 What 
outcomes matter to them, and their spouses 
and families? Once we know this we could try 
to gather evidence of effectiveness and cost 
effectiveness of treatment aimed at achieving 
goals that really matter to them. This would 
require taking a perspective that gave special 
attention to their limited life expectancy, limited 
functional and cognitive reserves, comorbid 
conditions, and their risks of experiencing an 
adverse outcome in the near future. A transition 
to a definition of appropriate health care based 
on desired outcomes seems warranted.
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